Deka Bank Deutsche Girozentrale Halozyme Therapeutics, Inc. Transaction History

Deka Bank Deutsche Girozentrale

$53.9 Billion
Q3 2024

A detailed history of Deka Bank Deutsche Girozentrale transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Deka Bank Deutsche Girozentrale holds 54,907 shares of HALO stock, worth $2.51 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

54,907

Previous 57,453 4.43%

Holding current value

$2.51 Million

Previous $2.96 Million 4.66%

% of portfolio

0.01%

Previous 0.01%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	SELL	$51.3 - $64.42 $130,609 - $164,013	-2,546 Reduced 4.43%	54,907 $3.1 Million
Q2 2024 Aug 08, 2024	BUY	$37.81 - $52.4 $96,264 - $133,410	2,546 Added 4.64%	57,453 $2.96 Million
Q1 2024 Apr 24, 2024	BUY	$33.68 - $41.95 $165,267 - $205,848	4,907 Added 9.81%	54,907 $2.22 Million
Q1 2023 Apr 24, 2023	SELL	$32.86 - $55.7 $883,934 - $1.5 Million	-26,900 Reduced 34.98%	50,000 $1.85 Million
Q4 2021 Feb 02, 2022	BUY	$31.82 - $40.75 $1.61 Million - $2.07 Million	50,700 Added 193.51%	76,900 $3.12 Million
Q4 2020 Mar 12, 2021	SELL	$25.81 - $43.62 $33,553 - $56,706	-1,300 Reduced 4.73%	26,200 $1.1 Million
Q3 2020 Oct 29, 2020	BUY	$25.74 - $29.63 $707,850 - $814,825	27,500 New	27,500 $720,000
Q4 2019 Feb 04, 2020	SELL	$14.93 - $19.53 $425,505 - $556,605	-28,500 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$15.2 - $17.69 $250,800 - $291,885	-16,500 Reduced 36.67%	28,500 $433,000
Q2 2019 Aug 01, 2019	BUY	$14.75 - $17.26 $258,125 - $302,050	17,500 Added 63.64%	45,000 $758,000
Q1 2019 May 10, 2019	BUY	$13.94 - $17.58 $69,700 - $87,899	5,000 Added 22.22%	27,500 $502,000
Q4 2018 Feb 12, 2019	SELL	$13.33 - $18.66 $66,650 - $93,300	-5,000 Reduced 18.18%	22,500 $323,000
Q3 2018 Nov 09, 2018	SELL	$16.68 - $18.41 $11,676 - $12,887	-700 Reduced 2.48%	27,500 $0
Q2 2018 Aug 14, 2018	SELL	$16.87 - $20.3 $590,450 - $710,500	-35,000 Reduced 55.38%	28,200 $480,000
Q1 2018 May 03, 2018	SELL	$17.06 - $21.2 $56,297 - $69,960	-3,300 Reduced 4.96%	63,200 $1.2 Million
Q3 2017 Nov 06, 2017	BUY	$11.76 - $17.4 $782,040 - $1.16 Million	66,500	66,500 $793,000

Others Institutions Holding HALO

# of Institutions

542

Shares Held

125M

Call Options Held

294K

Put Options Held

180K

View Full List

About HALOZYME THERAPEUTICS, INC.

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $6.36B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

More about HALO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deka Bank Deutsche Girozentrale, based on Form 13F filings with the SEC.

News

Stay updated on Deka Bank Deutsche Girozentrale with notifications on news.

Account

Deka Bank Deutsche Girozentrale Halozyme Therapeutics, Inc. Transaction History